Paediatric Cogan´s syndrome - review of literature, case report and practical approach to diagnosis and management
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu kazuistiky, časopisecké články, přehledy
PubMed
37291629
PubMed Central
PMC10251673
DOI
10.1186/s12969-023-00830-x
PII: 10.1186/s12969-023-00830-x
Knihovny.cz E-zdroje
- Klíčová slova
- Children, Clinical characteristics, Cogan´s syndrome, Course, Outcome, Practical approach,
- MeSH
- apraxie * vrozené MeSH
- Coganův syndrom * komplikace diagnóza terapie MeSH
- dítě MeSH
- keratitida * diagnóza terapie komplikace MeSH
- lidé MeSH
- percepční nedoslýchavost * diagnóza etiologie terapie MeSH
- prognóza MeSH
- progrese nemoci MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- přehledy MeSH
BACKGROUND: Cogan´s syndrome is a rare, presumed autoimmune vasculitis of various vessels characterized by interstitial keratitis and vestibular impairment accompanied by sensorineural hearing loss. Due to the rarity of Cogan´s syndrome in children, therapeutic decision making may be challenging. Therefore, a literature search was performed to collect all published paediatric Cogan´s syndrome cases with their clinical characteristics, disease course, treatment modalities used and their outcome. The cohort was supplemented with our own patient. MAIN TEXT: Altogether, 55 paediatric Cogan´s syndrome patients aged median 12 years have been reported so far. These were identified in PubMed with the keywords "Cogan´s syndrome" and "children" or "childhood". All patients suffered from inflammatory ocular and vestibulo-auditory symptoms. In addition, 32/55 (58%) manifested systemic symptoms with musculoskeletal involvement being the most common with a prevalence of 45%, followed by neurological and skin manifestations. Aortitis was detected in 9/55 (16%). Regarding prognosis, remission in ocular symptoms was attained in 69%, whereas only 32% achieved a significant improvement in auditory function. Mortality was 2/55. Our patient was an 8 year old girl who presented with bilateral uveitis and a history of long standing hearing deficit. She also complained of intermittent vertigo, subfebrile temperatures, abdominal pain with diarrhoea, fatigue and recurrent epistaxis. The diagnosis was supported by bilateral labyrinthitis seen on contrast-enhanced magnetic resonance imaging. Treatment with topical and systemic steroids was started immediately. As the effect on auditory function was only transient, infliximab was added early in the disease course. This led to a remission of ocular and systemic symptoms and a normalization of hearing in the right ear. Her left ear remained deaf and the girl is currently evaluated for a unilateral cochlear implantation. CONCLUSIONS: This study presents an analysis of the largest cohort of paediatric Cogan´s syndrome patients. Based on the collected data, the first practical guide to a diagnostic work-up and treatment in children with Cogan´s syndrome is provided.
3rd Faculty of Medicine Charles University Prague Czech Republic
Clinic for Rheumatology and Immunology Bad Bramstedt Bad Bramstedt Germany
Klinikum Stuttgart Kriegsbergstraße 60 70174 Stuttgart Germany
Zobrazit více v PubMed
Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17:603–606. doi: 10.1007/s10157-013-0869-6. PubMed DOI PMC
Cogan DG. Nonsyphilitic Interstitial Keratitis With Vestibuloauditory Symptoms. Arch Ophthalmol. 1964;71:172. doi: 10.1001/archopht.1964.00970010188005. PubMed DOI
Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine. 1980;59:426–441. doi: 10.1097/00005792-198011000-00003. PubMed DOI
Grasland A. Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology. 2004;43:1007–1015. doi: 10.1093/rheumatology/keh228. PubMed DOI
Gluth MB, Baratz KH, Matteson EL, Driscoll CLW. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc. 2006;81:483–488. doi: 10.4065/81.4.483. PubMed DOI
Tayer-Shifman OE, Ilan O, Tovi H, Tal Y. Cogan’s syndrome—clinical guidelines and novel therapeutic approaches. Clin Rev Allergy Immunol. 2014;47:65–72. doi: 10.1007/s12016-013-8406-7. PubMed DOI
Iliescu DA, Timaru CM, Batras M, de Simone A, Stefan C. Cogan’s syndrome. Rom J Ophthalmol. 2015;59:6–13. PubMed PMC
Brogan K, Eleftheriou D, Rajput K, Edelsten C, Sebire NJ, Brogan PA. Tubulointerstitial nephritis, uveitis, hearing loss and vestibular failure: TINU-atypical Cogan’s overlap syndrome. Rheumatology. 2012;51:950–952. doi: 10.1093/rheumatology/ker443. PubMed DOI
Mace AD, Ferguson MS, Offer M, Ghufoor K, Wareing MJ. Bilateral profound sudden sensorineural hearing loss presenting a diagnostic conundrum in a child with sickle cell anaemia. J Laryngol Otol. 2009;123:811–816. doi: 10.1017/S0022215108003617. PubMed DOI
Pagnini I, Zannin ME, Vittadello F, Sari M, Simonini G, Cimaz R, et al. Clinical features and outcome of Cogan syndrome. J Pediatr. 2012;160:303–307.e1. doi: 10.1016/j.jpeds.2011.07.051. PubMed DOI
Pollard ZF. Uveitis associated with atypical Cogan syndrome in children. Arch Ophthalmol. 2007;125:1574. doi: 10.1001/archopht.125.11.1574. PubMed DOI
García Callejo FJ, Costa Alcácer I, Blay Galaud L, Sebastián Gil E. Platero Zamarreño A [Inner ear autoimmune disorder. Cogan’s syndrome] An Esp Pediatr. 2001;55:87–91. PubMed
Andler W, Hülse M, Bruch PM. Partsch CJ [Cogans’s syndrome in childhood (author’s transl)] Monatsschr Kinderheilkd. 1977;125:161–164. PubMed
Inoue Y, Tomemori T, Suzuki S, Arima T, Tomiita M, Shimojo N, et al. Low-dose oral methotrexate for the management of childhood Cogan’s syndrome: a case report. Clin Rheumatol. 2007;26:2201–2203. doi: 10.1007/s10067-007-0686-y. PubMed DOI
Schwegmann JP, Enzenauer RJ. Cogan’s syndrome mimicking acute Lyme arthritis. Am J Orthop (Belle Mead NJ) 1995;24:426–428. PubMed
Hautefort C, Loundon N, Montchilova M, Marlin S, Garabedian EN, Ulinski T. Mycophenolate mofetil as a treatment of steroid dependent Cogan’s syndrome in childhood. Int J Pediatr Otorhinolaryngol. 2009;73:1477–1479. doi: 10.1016/j.ijporl.2009.06.025. PubMed DOI
Ndiaye IC, Rassi SJ, Wiener-Vacher SR. Cochleovestibular impairment in pediatric Cogan’s syndrome. Pediatrics. 2002;109:e38–e38. doi: 10.1542/peds.109.2.e38. PubMed DOI
Juneja M, Jain R, Chakarbarty B. Atypical Cogan syndrome mimicking acute rheumatic fever. Indian Pediatr. 2011;48:561–563. PubMed
Kolomeyer AM, Kodati S. Lamotrigine-induced tubulointerstitial nephritis and uveitis-atypical Cogan syndrome. Eur J Ophthalmol. 2016;26:14–16. doi: 10.5301/ejo.5000674. PubMed DOI
Martinez-Osorio H, Fuentes-Paez G, Calonge M. Severe keratopathy in paediatric Cogan’s syndrome. Rheumatology. 2006;45:1576–1577. doi: 10.1093/rheumatology/kel321. PubMed DOI
Massinger C, Keilmann A. Das Cogan-I-Syndrom. HNO. 2003;51:66–70. doi: 10.1007/s00106-002-0707-8. PubMed DOI
Pysden KS, Long V, Ferrie CD, Leeds Teaching Hospitals NHS Trust Cogan’s syndrome: a rare cause of meningoencephalitis. J Child Neurol. 2009;24:753–7. doi: 10.1177/0883073808329533. PubMed DOI
Son HJ, Ulualp SO. Course of auditory impairment in Cogan’s syndrome. Am J Otolaryngol. 2009;30:65–68. doi: 10.1016/j.amjoto.2008.02.003. PubMed DOI
Jančatová D, Zeleník K, Komínek P, Matoušek P. Atypical Cogan’s syndrome: a case report and summary of current treatment options. Int J Pediatr Otorhinolaryngol. 2015;79:428–431. doi: 10.1016/j.ijporl.2014.12.028. PubMed DOI
Vasileiadis I, Stratoudaki R, Karakostas E. Complete restoration of auditory impairment in a pediatric case of Cogan’s syndrome: report of a rare case with long-term follow-up and literature review. Int J Pediatr Otorhinolaryngol. 2012;76:601–605. doi: 10.1016/j.ijporl.2012.01.017. PubMed DOI
Sugimoto K, Miyazawa T, Nishi H, Izu A, Enya T, Okada M, et al. Childhood Cogan syndrome with aortitis and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Pediatr Rheumatol. 2014;12:15. doi: 10.1186/1546-0096-12-15. PubMed DOI PMC
Olfat M, Al-Mayouf S. Cogan’s syndrome in childhood. Rheumatol Int. 2001;20:246–249. doi: 10.1007/s002960100123. PubMed DOI
Orsoni JG, Zavota L, Vincenti V, Pellistri I, Rama P. Cogan syndrome in children: early diagnosis and treatment is critical to prognosis. Am J Ophthalmol. 2004;137:757–758. doi: 10.1016/S0002-9394(03)01122-X. PubMed DOI
Podder S, Shepherd RC. Cogan’s syndrome: a rare systemic vasculitis. Arch Dis Child. 1994;71:163–164. doi: 10.1136/adc.71.2.163. PubMed DOI PMC
Vaiopoulos G, Sfikakis PP, Skoumas B, Kavouklis E, Doukas E, Kaklamanis Ph. Lack of response to corticosteroids and pulse cyclophosphamide therapy in Cogan’s syndrome. Clin Rheumatol. 1994;13:110–112. doi: 10.1007/BF02229876. PubMed DOI
Ochonisky S, Chosidow O, Kuentz M, Man N, Fraitag S, Pelisse JM, et al. Cogan’s syndrome. An unusual etiology of urticarial vasculitis. Dermatologica. 1991;183:218–20. doi: 10.1159/000247674. PubMed DOI
Chaudhuri K, Das RR, Chinnakkannan S. Reversible severe sensorineural hearing loss in a 7-year-old child (case presentation) Acta Paediatr. 2011;100:322–323. doi: 10.1111/j.1651-2227.2010.02050.x. PubMed DOI
Saraux H, Bechetoille A. Cogan’s kerato-cochlear syndrome. Apropos of 3 cases. Ann Ocul (Paris) 1972;205:431–5. PubMed
Bachynski B, Wise J. Cogan’s syndrome: a treatable cause of neurosensory deafness. Can J Ophthalmol. 1984;19:145–147. PubMed
Dufier JL, Orssaud C, Virelizier JL, Babinet JM, de Prost Y, Griscelli C. A rare cause of episcleritis: Cogan’s syndrome. Bull Soc Ophtalmol Fr. 1986;86:967–969. PubMed
Low AHL, Su JW, Sin KYK, Fong KY, Thumboo J. Cogan’s syndrome with recurrent carotid and aortic aneurysms: a potentially fatal disorder mimicking Marfan syndrome. Scand J Rheumatol. 2007;36:71–73. doi: 10.1080/03009740600907923. PubMed DOI
Kundell SP, Ochs HD. Cogan syndrome in childhood. J Pediatr. 1980;97:96–98. doi: 10.1016/S0022-3476(80)80142-9. PubMed DOI
Pinals RS. Cogan’s syndrome with arthritis and aortic insufficiency. J Rheumatol. 1978;5:294–298. PubMed
Kasapçopur O, Ashraf M, Caliskan S, Aktuglu C, Aslan OS, Oz F, et al. Cogan’s syndrome: a rare vasculitis in childhood. J Rheumatol. 2000;27:1824–1825. PubMed
Watanabe K, Nishimaki T, Yoshida M, Shinzawa J, Yoshioka R, Suzuki S, et al. Atypical Cogan’s syndrome successfully treated with corticosteroids and pulse cyclophosphamide therapy. Fukushima J Med Sci. 2000;46:49–54. doi: 10.5387/fms.46.49. PubMed DOI
Xie L, Cai Y, Bao X, Cao L. Leflunomide for the successful management of juvenile Cogan’s syndrome. Clin Rheumatol. 2009;28:1453–1455. doi: 10.1007/s10067-009-1263-3. PubMed DOI
Kasap Cuceoglu M, Basaran O, Batu ED, Kaya Akca U, Atalay E, Sener S, et al. Report of 2 pediatric cases with atypical Cogan’s syndrome and a systematic review. Int J Rheum Dis. 2022;00:1–7. PubMed
Lunardi C, Bason C, Leandri M, Navone R, Lestani M, Millo E, et al. Autoantibodies to inner ear and endothelial antigens in Cogan’s syndrome. The Lancet. 2002;360:915–921. doi: 10.1016/S0140-6736(02)11028-2. PubMed DOI
Bonaguri C, Orsoni J, Russo A, Rubino P, Bacciu S, Lippi G, et al. Cogan’s syndrome: anti-Hsp70 antibodies are a serological marker in the typical form. Isr Med Assoc J. 2014;16:285–288. PubMed
Espinoza GM, Wheeler J, Temprano KK, Keller AP. Cogan’s Syndrome: Clinical Presentations and Update on Treatment. Curr Allergy Asthma Rep. 2020;20:46. doi: 10.1007/s11882-020-00945-1. PubMed DOI
D’Aguanno V, Ralli M, de Vincentiis M, Greco A. Optimal management of Cogan’s syndrome: a multidisciplinary approach. J Multidiscip Healthc. 2017;11:1–11. doi: 10.2147/JMDH.S150940. PubMed DOI PMC
Durtette C, Hachulla E, Resche-Rigon M, Papo T, Zénone T, Lioger B, et al. Cogan syndrome: characteristics, outcome and treatment in a French nationwide retrospective study and literature review. Autoimmun Rev. 2017;16:1219–1223. doi: 10.1016/j.autrev.2017.10.005. PubMed DOI
Greco A, Gallo A, Fusconi M, Magliulo G, Turchetta R, Marinelli C, et al. Cogan’s syndrome: An autoimmune inner ear disease. Autoimmun Rev. 2013;12:396–400. doi: 10.1016/j.autrev.2012.07.012. PubMed DOI
Sakano H, Harris JP. Emerging options in immune-mediated hearing loss. Laryngoscope Investig Otolaryngol. 2019;4:102–108. doi: 10.1002/lio2.205. PubMed DOI PMC
Vashishth A, Fulcheri A, Prasad SC, Bassi M, Rossi G, Caruso A, et al. Cochlear implantation in cochlear ossification: retrospective review of etiologies, surgical considerations, and auditory outcomes. Otol Neurotol. 2018;39:17–28. doi: 10.1097/MAO.0000000000001613. PubMed DOI
Low WK, See JY, Ng WN, Fong A, Chew SH. An unusual case of post-cochlear implant performance degradation in a patient with suspected Cogan’s syndrome. Cochlear Implants Int. 2019;20:94–99. doi: 10.1080/14670100.2018.1548077. PubMed DOI
Low WK, Burgess R, Teoh CK. Cochlear implantation in a patient with Cogan‘s syndrome, chronic ear disease and on steroid therapy. Updates in cochlear implantation. Basel: KARGER; 2000. p. 157–9. PubMed
Aschendorff A, Lohnstein P, Schipper J, Klenzner T. Obliteration der Cochlea beim Cogan-Syndrom - Bedeutung für die Cochlear-Implant-Chirurgie. Laryngorhinootologie. 2004;83:836–839. doi: 10.1055/s-2004-826004. PubMed DOI
Pasanisi E, Vincenti V, Bacciu A, Guida M, Berghenti T, Barbot A, et al. Cochlear implantation and Cogan syndrome. Otol Neurotol. 2003;24:601–4. PubMed
Bovo R, Ciorba A, Trevisi P, Aimoni C, Cappiello L, Castiglione A, et al. Cochlear implant in Cogan syndrome. Acta Otolaryngol. 2011;131:494–497. doi: 10.3109/00016489.2010.535214. PubMed DOI
Kawamura S, Sakamoto T, Kashio A, Kakigi A, Ito K, Suzuki M, et al. Cochlear implantation in a patient with atypical Cogan’s syndrome complicated with hypertrophic cranial pachymeningitis. Auris Nasus Larynx. 2010;37:737–741. doi: 10.1016/j.anl.2010.04.005. PubMed DOI
Vishwakarma R, Shawn TJ. Cochlear implant in Cogan’s syndrome. Eur Arch Otorhinolaryngol. 2007;264:1121–1124. doi: 10.1007/s00405-007-0362-5. PubMed DOI
Cinamon U, Kronenberg J, Hildesheimer M, Taitelbaum R. Cochlear implantation in patients suffering from Cogan’s syndrome. J Laryngol Otol. 1997;111:928–930. doi: 10.1017/S002221510013899X. PubMed DOI
Wang JR, Yuen HW, Shipp DB, Stewart S, Lin VYW, Chen JM, et al. Cochlear implantation in patients with autoimmune inner ear disease including cogan syndrome: a comparison with age- and sex-matched controls. Laryngoscope. 2010;120:2478–2483. doi: 10.1002/lary.21060. PubMed DOI
Quaranta N, Bartoli R, Giagnotti F, di Cuonzo F, Quaranta A. Cochlear implants in systemic autoimmune vasculitis syndromes. Acta Otolaryngol. 2002;122:44–48. doi: 10.1080/00016480260094974. PubMed DOI
Cassis AM. cochlear ossification in a patient with Cogan’s syndrome undergoing bilateral cochlear implantation. Case Rep Otolaryngol. 2018;2018:1–2. doi: 10.1155/2018/7395460. PubMed DOI PMC
Minet M, Deggouj N, Gersdorff M. Cochlear implantation in patients with Cogan’s syndrome: a review of four cases. Eur Arch Otorhinolaryngol. 1997;254:459–462. doi: 10.1007/BF02439981. PubMed DOI
Kontorinis G, Giourgas A, Neuburger J, Lesinski-Schiedat A, Lenarz T. Long-term evaluation of cochlear implantation in Cogan syndrome. ORL. 2010;72:275–279. doi: 10.1159/000318870. PubMed DOI
Bacciu A, Pasanisi E, di Lella F, Guida M, Bacciu S, Vincenti V. Cochlear implantation in patients with Cogan syndrome: long-term results. Eur Arch Otorhinolaryngol. 2015;272:3201–3207. doi: 10.1007/s00405-014-3376-9. PubMed DOI
Parnes LS, Sun A-H, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109:1–17. doi: 10.1097/00005537-199907001-00001. PubMed DOI